Skip to main content

Nippon Shokubai and Sanyo Chemical to merge

4th June 2019

Submitted by:

Andrew Warmington

Japanese firms Nippon Shokubai and Sanyo Chemical Industries have entered into a basic agreement on a merger of equals, which should be completed in around December. Financial details were not disclosed and a final agreement has yet to be signed, but the current plan is to form a holding company and centralise their corporate functions, while operations will continue operating independently.

Nippon Shokubai is mainly active in basic chemicals, such as acrylic acid and ethylene oxide, plus high-performance functional chemicals and environmental and catalyst products based on them. Sanyo, meanwhile, is more focused on performance chemicals based on its surface activity control technology, supplying some 3,000 in all. They are both active in superabsorbent polymers (SAPs).

The two said that the agreement was driven by several factors, including the need for greater scale to address emerging markets and compete with larger European and American firms, especially in view of projected falling demand in Japan itself. In addition, the SAP market is seeing reduced profitability despite growing demand, with many regional players emerging.

Both had already set out medium-term plans to address these issues and saw that they had a “mutual complementary relationship”. Nippon Shokubai has a strong in-house value chain but is struggling to create new businesses to meet user needs; Sanyo, meanwhile, is good at manufacturing and marketing performance chemicals but very dependent on external raw materials suppliers, including Nippon Shokubai.

“With such recognition, the companies were exchanging opinions on various options including a business integration, and have reached an understanding that executing a business integration with each other is the best way to make use of the companies’ strengths, solve the business challenges and create a synergy effect,” they stated.

Expected business advantages include: a strong base through integrated technology and cost savings, particularly in SAPs, plus enhanced R&D capabilities; greater competitiveness and profitability through scale expansion; diversification of the portfolio; and faster development of new business. An enhanced ability to address the UN’s 17 Sustainable Development Goals as a merged entity was also cited.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington